Literature DB >> 16705672

Neuropathologic and neuroinflammatory activities of HIV-1-infected human astrocytes in murine brain.

Huanyu Dou1, Justin Morehead, Jennifer Bradley, Santhi Gorantla, Brent Ellison, Jeff Kingsley, Lynette M Smith, Wei Chao, Galina Bentsman, David J Volsky, Howard E Gendelman.   

Abstract

The balance between astrocyte and microglia neuroprotection and neurotoxicity defines the tempo of neuronal dysfunction during HIV-1-associated dementia (HAD). Astrocytes maintain brain homeostasis and respond actively to brain damage by providing functional and nutritive neuronal support. In HAD, low-level, continuous infection of astrocytes occurs, but the functional consequences of this infection are poorly understood. To this end, human fetal astrocytes (HFA) and monocyte-derived macrophages (MDM) were infected with HIV-1DJV and HIV-1NL4-3 (neurotropic and lymphotropic strains respectively) and a pseudotyped Vesicular Stomatitis Virus (VSV/HIV-1NL4-3) prior to intracranial injection into the basal ganglia of severe combined immunodeficient mice. Neuropathological and immunohistochemical comparisons for inflammatory and neurotoxic activities were performed amongst the infected cell types at 7 or 14 days. HIV-1-infected MDM induced significant increases in Mac-1, glial fibrillary acidic protein, ionized calcium-binding adapter molecule 1, and proinflammatory cytokine RNA and/or protein expression when compared with HSV/HIV-1- and HIV-1-infected HFA and sham-operated mice. Levels of neuron-specific nuclear protein, microtubule-associated protein 2, and neurofilament antigens were reduced significantly in the brain regions injected with human MDM infected with HIV-1DJV or VSV/HIV-1. We conclude that HIV-1 infection of astrocytes leads to limited neurodegeneration, underscoring the early and active role of macrophage-driven neurotoxicity in disease. Copyright 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2006        PMID: 16705672     DOI: 10.1002/glia.20358

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  21 in total

Review 1.  Rodent models for HIV-associated neurocognitive disorders.

Authors:  Santhi Gorantla; Larisa Poluektova; Howard E Gendelman
Journal:  Trends Neurosci       Date:  2012-02-01       Impact factor: 13.837

2.  Neuromodulatory activities of CD4+CD25+ regulatory T cells in a murine model of HIV-1-associated neurodegeneration.

Authors:  Jianuo Liu; Nan Gong; Xiuyan Huang; Ashley D Reynolds; R Lee Mosley; Howard E Gendelman
Journal:  J Immunol       Date:  2009-03-15       Impact factor: 5.422

3.  Coinfection of hepatic cell lines with human immunodeficiency virus and hepatitis B virus leads to an increase in intracellular hepatitis B surface antigen.

Authors:  David M Iser; Nadia Warner; Peter A Revill; Ajantha Solomon; Fiona Wightman; Suha Saleh; Megan Crane; Paul U Cameron; Scott Bowden; Tin Nguyen; Cândida F Pereira; Paul V Desmond; Stephen A Locarnini; Sharon R Lewin
Journal:  J Virol       Date:  2010-03-31       Impact factor: 5.103

4.  Immune activation, viral gene product expression and neurotoxicity in the HIV-1 transgenic rat.

Authors:  Walter Royal; Li Zhang; Ming Guo; Odell Jones; Harry Davis; Joseph L Bryant
Journal:  J Neuroimmunol       Date:  2012-04-12       Impact factor: 3.478

5.  Identification and molecular characterization of SIV Vpr R50G mutation associated with long term survival in SIV-infected morphine dependent and control macaques.

Authors:  Ivelisse Rivera; Yashira García; Mohitkumar R Gangwani; Richard J Noel; Lucianette Maldonado; Anil Kumar; Vanessa Rivera-Amill
Journal:  Virology       Date:  2013-08-28       Impact factor: 3.616

6.  Soluble factors from IL-1β-stimulated astrocytes activate NR1a/NR2B receptors: implications for HIV-1-induced neurodegeneration.

Authors:  Tao Jing; Li Wu; Kathleen Borgmann; Sankar Surendran; Anuja Ghorpade; Jianuo Liu; Huangui Xiong
Journal:  Biochem Biophys Res Commun       Date:  2010-10-08       Impact factor: 3.575

7.  Cooperative induction of CXCL10 involves NADPH oxidase: Implications for HIV dementia.

Authors:  Rachel Williams; Honghong Yao; Fuwang Peng; Yanjing Yang; Crystal Bethel-Brown; Shilpa Buch
Journal:  Glia       Date:  2010-04       Impact factor: 7.452

8.  HIV-1 TAT inhibits microglial phagocytosis of Abeta peptide.

Authors:  Brian Giunta; Yuyan Zhou; Huayan Hou; Elona Rrapo; Francisco Fernandez; Jun Tan
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01

9.  HIV-1-infected astrocytes and the microglial proteome.

Authors:  Tong Wang; Nan Gong; Jianuo Liu; Irena Kadiu; Stephanie D Kraft-Terry; Joshua D Schlautman; Pawel Ciborowski; David J Volsky; Howard E Gendelman
Journal:  J Neuroimmune Pharmacol       Date:  2008-06-28       Impact factor: 4.147

10.  Roles of MCP-1 in development of HIV-dementia.

Authors:  Navneet Kaur Dhillon; Rachel Williams; Shannon Callen; Chris Zien; Opendra Narayan; Shilpa Buch
Journal:  Front Biosci       Date:  2008-05-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.